Orphapacket:
  AverageAgeOfOnsets:
  - AverageAgeOfOnset:
      value: Adolescent
  - AverageAgeOfOnset:
      value: Adult
  - AverageAgeOfOnset:
      value: Childhood
  DisorderType:
    PURL: http://www.orpha.net/ORDO/Orphanet_377788
    value: Disease
  ExternalReferences:
  - ExternalReference:
      DisorderMappingRelation: BTNT (ORPHAcode is broader than the targeted code used
        to represent it)
      Reference: '161400'
      Source: OMIM
  - ExternalReference:
      DisorderMappingRelation: BTNT (ORPHAcode is broader than the targeted code used
        to represent it)
      Reference: '605841'
      Source: OMIM
  - ExternalReference:
      DisorderMappingRelation: BTNT (ORPHAcode is broader than the targeted code used
        to represent it)
      Reference: '609039'
      Source: OMIM
  - ExternalReference:
      DisorderMappingRelation: BTNT (ORPHAcode is broader than the targeted code used
        to represent it)
      Reference: '612417'
      Source: OMIM
  - ExternalReference:
      DisorderMappingRelation: BTNT (ORPHAcode is broader than the targeted code used
        to represent it)
      Reference: '612851'
      Source: OMIM
  - ExternalReference:
      DisorderMappingRelation: BTNT (ORPHAcode is broader than the targeted code used
        to represent it)
      Reference: '614223'
      Source: OMIM
  - ExternalReference:
      DisorderMappingRelation: BTNT (ORPHAcode is broader than the targeted code used
        to represent it)
      Reference: '614250'
      Source: OMIM
  Genes:
  - Gene:
      DisorderGeneAssociationType: Major susceptibility factor in
      ExternalReferences:
      - Reference: HCRT
        Source: ClinVar
      - Reference: '4847'
        Source: HGNC
      - Reference: '602358'
        Source: OMIM
      Name: hypocretin neuropeptide precursor
      Symbol: HCRT
  - Gene:
      DisorderGeneAssociationType: Major susceptibility factor in
      ExternalReferences:
      - Reference: HLA-DRB1
        Source: ClinVar
      - Reference: '4948'
        Source: HGNC
      - Reference: '142857'
        Source: OMIM
      Name: major histocompatibility complex, class II, DR beta 1
      Symbol: HLA-DRB1
  - Gene:
      DisorderGeneAssociationType: Major susceptibility factor in
      ExternalReferences:
      - Reference: HLA-DQB1
        Source: ClinVar
      - Reference: '4944'
        Source: HGNC
      - Reference: '604305'
        Source: OMIM
      Name: major histocompatibility complex, class II, DQ beta 1
      Symbol: HLA-DQB1
  - Gene:
      DisorderGeneAssociationType: Major susceptibility factor in
      ExternalReferences:
      - Reference: MOG
        Source: ClinVar
      - Reference: '7197'
        Source: HGNC
      - Reference: '159465'
        Source: OMIM
      Name: myelin oligodendrocyte glycoprotein
      Symbol: MOG
  - Gene:
      DisorderGeneAssociationType: Major susceptibility factor in
      ExternalReferences:
      - Reference: '11934'
        Source: HGNC
      - Reference: '603594'
        Source: OMIM
      - Reference: TNFSF4
        Source: ClinVar
      Name: TNF superfamily member 4
      Symbol: TNFSF4
  - Gene:
      DisorderGeneAssociationType: Major susceptibility factor in
      ExternalReferences:
      - Reference: '8540'
        Source: HGNC
      - Reference: '602697'
        Source: OMIM
      - Reference: P2RY11
        Source: ClinVar
      Name: purinergic receptor P2Y11
      Symbol: P2RY11
  - Gene:
      DisorderGeneAssociationType: Major susceptibility factor in
      ExternalReferences:
      - Reference: '18194'
        Source: HGNC
      - Reference: '607818'
        Source: OMIM
      - Reference: ZNF365
        Source: ClinVar
      Name: zinc finger protein 365
      Symbol: ZNF365
  - Gene:
      DisorderGeneAssociationType: Major susceptibility factor in
      ExternalReferences:
      - Reference: '2535'
        Source: HGNC
      - Reference: '116820'
        Source: OMIM
      - Reference: CTSH
        Source: ClinVar
      Name: cathepsin H
      Symbol: CTSH
  Label: Narcolepsy type 1
  ORPHAcode: '2073'
  ORPHApacketId: '2073'
  PURL: http://www.orpha.net/ORDO/Orphanet_2073
  Parents:
  - Parent:
    - Label: Narcolepsy
      ORPHAcode: '619284'
  Phenotypes:
  - Phenotype:
      HPOFrequency: Frequent (79-30%)
      HPOId: HP:0007018
      HPOTerm: Attention deficit hyperactivity disorder
  - Phenotype:
      HPOFrequency: Frequent (79-30%)
      HPOId: HP:0007686
      HPOTerm: Abnormal pupillary function
  - Phenotype:
      HPOFrequency: Frequent (79-30%)
      HPOId: HP:0012452
      HPOTerm: Restless legs
  - Phenotype:
      HPOFrequency: Frequent (79-30%)
      HPOId: HP:0025235
      HPOTerm: Non-rapid eye movement parasomnia
  - Phenotype:
      HPOFrequency: Frequent (79-30%)
      HPOId: HP:0030014
      HPOTerm: Female sexual dysfunction
  - Phenotype:
      HPOFrequency: Frequent (79-30%)
      HPOId: HP:0040307
      HPOTerm: Male sexual dysfunction
  - Phenotype:
      HPOFrequency: Occasional (29-5%)
      HPOId: HP:0000711
      HPOTerm: Restlessness
  - Phenotype:
      HPOFrequency: Occasional (29-5%)
      HPOId: HP:0000716
      HPOTerm: Depression
  - Phenotype:
      HPOFrequency: Occasional (29-5%)
      HPOId: HP:0000826
      HPOTerm: Precocious puberty
  - Phenotype:
      HPOFrequency: Occasional (29-5%)
      HPOId: HP:0001279
      HPOTerm: Syncope
  - Phenotype:
      HPOFrequency: Occasional (29-5%)
      HPOId: HP:0001350
      HPOTerm: Slurred speech
  - Phenotype:
      HPOFrequency: Very frequent (99-80%)
      HPOId: HP:0000738
      HPOTerm: Hallucinations
  - Phenotype:
      HPOFrequency: Very frequent (99-80%)
      HPOId: HP:0001262
      HPOTerm: Excessive daytime somnolence
  - Phenotype:
      HPOFrequency: Very frequent (99-80%)
      HPOId: HP:0002360
      HPOTerm: Sleep abnormality
  - Phenotype:
      HPOFrequency: Very frequent (99-80%)
      HPOId: HP:0002524
      HPOTerm: Cataplexy
  - Phenotype:
      HPOFrequency: Very frequent (99-80%)
      HPOId: HP:0010534
      HPOTerm: Transient global amnesia
  - Phenotype:
      HPOFrequency: Frequent (79-30%)
      HPOId: HP:0000017
      HPOTerm: Nocturia
  - Phenotype:
      HPOFrequency: Frequent (79-30%)
      HPOId: HP:0000739
      HPOTerm: Anxiety
  - Phenotype:
      HPOFrequency: Frequent (79-30%)
      HPOId: HP:0000822
      HPOTerm: Hypertension
  - Phenotype:
      HPOFrequency: Frequent (79-30%)
      HPOId: HP:0000975
      HPOTerm: Hyperhidrosis
  - Phenotype:
      HPOFrequency: Frequent (79-30%)
      HPOId: HP:0002019
      HPOTerm: Constipation
  - Phenotype:
      HPOFrequency: Frequent (79-30%)
      HPOId: HP:0002307
      HPOTerm: Drooling
  - Phenotype:
      HPOFrequency: Frequent (79-30%)
      HPOId: HP:0002494
      HPOTerm: Abnormal rapid eye movement sleep
  - Phenotype:
      HPOFrequency: Frequent (79-30%)
      HPOId: HP:0002519
      HPOTerm: Hypnagogic hallucinations
  - Phenotype:
      HPOFrequency: Frequent (79-30%)
      HPOId: HP:0006896
      HPOTerm: Hypnopompic hallucinations
  - Phenotype:
      HPOFrequency: Occasional (29-5%)
      HPOId: HP:0001513
      HPOTerm: Obesity
  - Phenotype:
      HPOFrequency: Occasional (29-5%)
      HPOId: HP:0002076
      HPOTerm: Migraine
  - Phenotype:
      HPOFrequency: Occasional (29-5%)
      HPOId: HP:0010535
      HPOTerm: Sleep apnea
  - Phenotype:
      HPOFrequency: Occasional (29-5%)
      HPOId: HP:0025233
      HPOTerm: Sleep paralysis
  - Phenotype:
      HPOFrequency: Very rare (<4-1%)
      HPOId: HP:0000709
      HPOTerm: Psychosis
  Prevalences:
  - Prevalence:
      PrevalenceClass: 1-5 / 10 000
      PrevalenceGeographic: Europe
      PrevalenceQualification: Value and class
      PrevalenceType: Point prevalence
      Source: 24849861[PMID]_[EXPERT]
      ValMoy: no data
  - Prevalence:
      PrevalenceClass: 1-9 / 1 000 000
      PrevalenceGeographic: United States
      PrevalenceQualification: Value and class
      PrevalenceType: Annual incidence
      Source: 11902429[PMID]
      ValMoy: no data
  - Prevalence:
      PrevalenceClass: 1-5 / 10 000
      PrevalenceGeographic: Norway
      PrevalenceQualification: Value and class
      PrevalenceType: Point prevalence
      Source: 19456307[PMID]_24849861[PMID]
      ValMoy: no data
  - Prevalence:
      PrevalenceClass: 1-5 / 10 000
      PrevalenceGeographic: Finland
      PrevalenceQualification: Value and class
      PrevalenceType: Point prevalence
      Source: 8210228[PMID]_24849861[PMID]
      ValMoy: no data
  - Prevalence:
      PrevalenceClass: 1-5 / 10 000
      PrevalenceGeographic: China
      PrevalenceQualification: Value and class
      PrevalenceType: Point prevalence
      Source: 11164060[PMID]_24849861[PMID]
      ValMoy: no data
  - Prevalence:
      PrevalenceClass: 1-5 / 10 000
      PrevalenceGeographic: United States
      PrevalenceQualification: Value and class
      PrevalenceType: Point prevalence
      Source: 11902429[PMID]_19013100[PMID]_24849861[PMID]_ORPHANET
      ValMoy: no data
  - Prevalence:
      PrevalenceClass: 1-5 / 10 000
      PrevalenceGeographic: United Kingdom
      PrevalenceQualification: Value and class
      PrevalenceType: Point prevalence
      Source: 8894197[PMID]_24849861[PMID]
      ValMoy: no data
  Synonyms:
  - Synonym: GÃ©lineau disease
  - Synonym: Narcolepsy-cataplexy
  - Synonym: Hypocretin/orexin deficiency syndrome
  TextSection:
    Contents: A rare neurologic disease characterized by excessive daytime sleepiness
      associated with uncontrollable sleep urges and cataplexy (sudden loss of muscle
      tone while awake often triggered by pleasant emotions).
    TextSectionType: Definition
  TypeOfInheritances:
    TypeOfInheritance:
    - value: Unknown
  copyright: Orphanet (c) 2025
  creationDate: '2025-12-09 10:41:42'
  version: 1.3.42 / 4.1.8 [2025-03-03]
